New Potential Marker of Breast Cancer Metastasis

Mi R-24-3p could be a potential novel marker of breast cancer metastases in breast cancer.

Using nanostring and RNA-sequencing technologies, mi R-24-3p has been identified as a potential novel marker of breast cancer metastases. The study was conducted by research teams at NYU School of Medicine, the Perlmutter Cancer Center, UT MD Anderson Cancer Center, and the University of Massachusetts Medical School.

Despite improvements in local, regional and systemic therapies for breast cancer, 40,610 women are expected to die from metastatic breast cancer in the US in 2017.

Breast Cancer Screening using Mammogram
Breast cancer if detected early can be completely cured. Mammography is used to screen women for breast cancer.

‘Mi R-24-3p is highly expressed in metastatic breast cancer tissue compared to primary breast cancer tissue.’

Therefore, there is a need to identify novel prognostic and predictive markers of occult metastases to better individualize adjuvant systemic therapy and develop new therapeutic approaches to eradicate occult metastases in women with early-stage breast cancer.

Furthermore, there are limited data regarding molecular mechanisms for single mi RNAs or mi RNA signatures that may impact prognosis in breast cancer patients.

Using nanostring and RNA-sequencing technologies researchers from the NYU School of Medicine, the Perlmutter Cancer Center, UT MD Anderson Cancer Center, and the University of Massachusetts Medical School identified mi R-24-3p as a potential novel marker of breast cancer metastases in breast cancer.

Consumption of Red Meat Increases Breast Cancer Risk
Red meat consumption has long been suspected of contributing to cancer development. Find out how much red meat is too much.

"In assessing the prognostic role of a panel of mi RNAs in breast cancer, we collected plasma at the time of initial diagnosis from 1,780 patients with stage I-III breast cancer prior to definitive treatment."

They went on to determine the expression of mi RNAs in primary and metastatic breast cancer samples from The Cancer Genome Atlas.

Inflammatory Breast Cancer - Causes, Symptoms, Diagnosis, Treatment & Prognosis
One of the rare breast cancers, inflammatory breast cancer is marked by redness, swelling and warmth of the breast skin looking like an orange peel.

Cancer, breast cancer and proteoglycans were the top three pathways affected by mi R-24-3p overexpression.

"We found that mir-24-3p is highly expressed in metastatic breast cancer tissue compared to primary breast cancer tissue, and that those tumors show specific gene expression signature."

Male Breast Cancer-Causes-Risk Factors-Signs-Symptoms-Diagnosis-Treatment-FAQs
Most cases of male breast cancer are diagnosed between the ages of 60 and 70 years. Treatment of male breast cancer often involves surgery.

Mi R-24-3p was expressed at high levels in the plasma from early-stage breast cancer patients destined to metastasize despite best available therapy, and in primary breast cancer tissue from patients who presented with stage IV at the time of diagnosis.

High expression of mir-24-3p in primary breast cancer tissues correlated with a poor survival rate in TCGA. These data strongly suggest mir-24-3p is involved in the metastatic process in breast cancer patients.

RNA-Seq data of the samples with the highest mi R-24-3p expression versus those with the lowest mi R-24-3p in the TCGA cohort identified a specific gene expression signature for those tumors with high mi R-24-3p.

Source-Eurekalert